Patient-reported outcome measures for lupus nephritis: content validity of LupusQoL and FACIT-Fatigue

Autor: Mona L. Martin, Jennifer N. Hill, Jennifer L. Rogers, Deven Chauhan, Wen-Hung Chen, Kerry Gairy

Publikováno v: Journal of Patient-Reported Outcomes, Vol 8, Iss 1, Pp 1-14 (2024)

Abstract Background Lupus nephritis (LN), a severe organ manifestation of systemic lupus erythematosus (SLE), significantly impacts health-related quality of life (HRQoL). Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-Fatigue) and L

Externí odkaz: https://doaj.org/article/7f0a69c74b7d40fb84de70abb4222a55

Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks

Autor: Michelle Petri, George K Bertsias, Antonis Fanouriakis, Binod Neupane, Roger A Levy, Amber Martin, Deven Chauhan, Pragya Shukla, Mahmoud Slim, Alfred H J Kim, Nick Ballew

Publikováno v: Lupus Science and Medicine, Vol 10, Iss 1 (2023)

Objective To generate comparative efficacy evidence of belimumab versus anifrolumab in SLE that can inform treatment practices.Methods The SLE Responder Index (SRI)-4 response at 52 weeks of belimumab versus anifrolumab was evaluated with an indirect

Externí odkaz: https://doaj.org/article/c05bce6bfaa5439c9a139fb5d54d75d3

Evaluating disease control following belimumab treatment in patients with SLE enrolled in the US OBSErve study

Autor: Holly Quasny, Anna Richards, Jacob N Hunnicutt, Jolyon Fairburn-Beech, Mary Elizabeth Georgiou, Yun Irene Gregan, Deven Chauhan

Publikováno v: Lupus Science and Medicine, Vol 9, Iss 1 (2022)

Objective To characterise disease control and remission in patients with SLE receiving belimumab for up to 12 months in the real world.Methods This post hoc analysis (GSK Study 213502) used data from the US evaluation Of use of Belimumab in clinical

Externí odkaz: https://doaj.org/article/303ee4aa6c3549a285688637e6c39a4a

Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus

Autor: Murray B. Urowitz, Cynthia Aranow, Yumi Asukai, Damon L. Bass, Ian N. Bruce, Deven Chauhan, Maria Dall'Era, Richard Furie, Norma Lynn Fox, Jennifer A. Gilbride, Anne Hammer, Ellen M. Ginzler, Tania Gonzalez‐Rivera, Roger A. Levy, Joan T. Merrill, Holly Quasny, David A. Roth, William Stohl, Ronald van Vollenhoven, Daniel J. Wallace, Michelle Petri

Publikováno v: Urowitz, M B, Aranow, C, Asukai, Y, Bass, D L, Bruce, I N, Chauhan, D, Dall'Era, M, Furie, R, Fox, N L, Gilbride, J A, Hammer, A, Ginzler, E M, Gonzalez-Rivera, T, Levy, R A, Merrill, J T, Quasny, H, Roth, D A, Stohl, W, van Vollenhoven, R, Wallace, D J & Petri, M 2022, ' Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus ', Arthritis Care and Research, vol. 74, no. 11, pp. 1822-1828 . https://doi.org/10.1002/acr.24901

Organ damage is a key determinant of poor long-term prognosis and early death in patients with systemic lupus erythematosus (SLE). Prevention of damage is a key treatment goal of the 2019 update of the European Alliance of Associations for Rheumatolo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c81a899c9b46ed97a967794594c7bb5
http://www.scopus.com/inward/record.url?scp=85135523522&partnerID=8YFLogxK

A qualitative exploration of the patient experience of erosive and non-erosive hand osteoarthritis

Autor: Sally Gatsi, Sofia Fernandes, Jane R. Wells, Charlotte Panter, Josephine Park, Deven Chauhan, Rob Arbuckle, Pamela Berry

Publikováno v: Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-17 (2021)
Journal of Patient-Reported Outcomes

Background Many patients with hand osteoarthritis (HOA) experience reduced health-related quality of life. This study sought to better understand the disease and treatment experience of individuals with HOA, explore any differences in experiences bet

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18f59ecf3431b704f65288c8192177ca
https://doaj.org/article/4ea8ab4da96a494fafd0d9697a1ef74a